Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 7 USDMF, 7 CEP/COS, 1 JDMF, 3 EU WC, 2 NDC API, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 30 FDA Orange Book, 2 Europe, 4 Canada, 8 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL, INJECTABLE;INJECTION - EQ 250MG BASE/VIAL, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

2 Topical, 1 Parenteral, 1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

11 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 JP

2 JP

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1CIPLA

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

CIPLA

HYDROCORTISONE SODIUM SUCCINATE

The Pharmacy Technology

Not Confirmed

Contact us
to update this info